Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Citigroup Inc. (C): Preferred-Stock Investors Now More Risk-Tolerant With Bank Preferreds

Page 1 of 2

Rating agencies and preferred stock investors, while using different methods, usually judge the investment risk of a preferred stock with little disparity. Where agency ratings come in the form of a quantitative rating on a scale, investors’ conclusions about risk are reflected in today’s market price (and thus today’s yield).

Preferred stocks that are viewed as having similar risk frequently have similar yields — same risk, same reward. But what about when there is a disconnect between the risk as assessed by the rating agencies and that assessed by investors? Who’s right?

Citigroup Inc (NYSE:C)

There and back again
We learned during the global credit crisis that agency ratings were imperfect for a variety of reasons. Shortcomings of both mathematics and character led to grossly inaccurate ratings in too many cases. This was especially true with preferred stocks issued by banks.

But historically, in the absence of such crisis conditions, agency ratings have served millions of investors well for many decades. And as imperfect as these ratings are, the fact is that most investors have little choice but to use such ratings as a proxy for investment risk.

In fact, looking at the most recently introduced bank preferred stocks, it appears that the tides of doubt have turned entirely. With this most recent crop, Moody’s is saying that the preferred stocks issued by banks represent more risk than investors seem to think — exactly the opposite situation that preferred-stock investors faced not so long ago.

Take a look at this chart. Each diamond on this chart represents one of the 36 preferred stocks issued within the last six months that have been rated by Moody’s Investors Service (this total includes 27 preferred stocks and nine exchange-traded debt securities, or ETDs. ETDs are very similar to preferred stocks and are often classified as such by brokerage systems).

The blue “best fit” line indicates the reward (as measure by current yield) being paid by these new preferred stocks at each risk level (as declared by Moody’s). Moody’s investment grade ratings (strongest to weakest) are Aaa, Aa1, Aa2, Aa3, A1, A2, A3, Baa1, Baa2 and Baa3 while Moody’s speculative grade ratings are Ba1, Ba2, Ba3, B1, B2, B3, Caa1, Caa2, Caa3, Ca and C. Note how the yield demanded by preferred stock investors goes up with risk — no surprise there.

Bank preferreds rated too low?
The table below the chart does the math for you. For example, as a group, today’s preferred-stock investors are demanding a reward of 6.6% at the “Baa3” risk level (the lowest investment-grade Moody’s rating).

During the crisis years, Citigroup Inc. (NYSE:C) was the poster child for what came to be known as “too big to fail,” or TBTF, banks. Earlier this year, Citigroup Inc. (NYSE:C) introduced a new noncumulative traditional preferred stock with a 5.8% dividend rate (coupon). Moody’s has issued this security a “B1” rating — four notches into speculative-grade territory.

In today’s market, a preferred stock at the “B1” risk level commands a current yield of 7.5%. But look at Citigroup Inc. (NYSE:C)’s preferred stock, “C-C,” on the chart: The market has priced C-C such that it finds buyers at a current yield of 6.6% — a level of reward that is more consistent with preferred stocks with a much stronger “Baa3” investment grade Moody’s rating.

Moody’s is saying that C-C’s risk is consistent with its “B1” rating, while investors are saying that C-C represents a much lower risk level (“Baa3”).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!